Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80
暂无分享,去创建一个
[1] V. Ling,et al. Mechanism of multidrug resistance. , 1988, Biochimica et biophysica acta.
[2] K. Hande,et al. Etoposide pharmacology. , 1992, Seminars in oncology.
[3] B. Sikic,et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Baas,et al. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. , 1993, Pharmacology & therapeutics.
[5] J. Laissue,et al. Pharmacologic interactions between the resistance‐modifying cyclosporine sdz psc 833 and etoposide (VP 16–213) enhance In Vivo cytostatic activity and toxicity , 1992, International journal of cancer.
[6] D. Housman,et al. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. , 1992, The Journal of biological chemistry.
[7] J Moan,et al. Interaction of cremophor EL with human plasma. , 1991, International Journal of Biochemistry.
[8] M. Millward,et al. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. , 1993, Journal of the National Cancer Institute.
[9] B. Williams,et al. Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. , 1990, Cancer research.
[10] M. Zucchetti,et al. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. , 1994, The Journal of pharmacology and experimental therapeutics.
[11] S. M. McAfee,et al. Tween 80 increases plasma adriamycin concentrations in mice by an apparent reduction of plasma volume. , 1981, European journal of cancer.
[12] J. B. Vermorken,et al. The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance. , 1990, British Journal of Cancer.
[13] W. Scheithauer,et al. Clinical trials of agents that reverse multidrug resistance. A literature review , 1993, Cancer.
[14] D. Kessel,et al. Effects of Cremophor EL on distribution of Taxol to serum lipoproteins. , 1994, British Journal of Cancer.
[15] M. Sehested,et al. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. , 1990, Cancer communications.
[16] H. Chaimovich,et al. Effect of Detergents and Other Amphiphiles on the Stability of Pharmaceutical Drugs , 1993, The Journal of pharmacy and pharmacology.
[17] P. Gros,et al. Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.
[18] B. Sikic,et al. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. Sawyer,et al. Reversal of multidrug resistance by surfactants. , 1992, British journal of cancer.
[20] D. Kessel. PROPERTIES OF CREMOPHOR EL MICELLES PROBED BY FLUORESCENCE , 1992, Photochemistry and photobiology.
[21] J. Anderson,et al. Effects of verapamil on the acute toxicity of doxorubicin in vivo. , 1992, Journal of the National Cancer Institute.
[22] F. Sinicrope,et al. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. , 1992, The Journal of biological chemistry.
[23] J. McCormack,et al. Influence of hypoxia on the metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver. , 1986, Biochemical Pharmacology.
[24] T. Thalhammer,et al. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver. , 1994, Anticancer research.
[25] T. Tsuruo,et al. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] Y. Sawada,et al. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine. , 1992, Journal of hepatology.
[27] T. Okano,et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. , 1990, Cancer research.
[28] C. Tebbi,et al. Reversal of C1300 murine neuroblastoma multidrug resistance by cremophorEL, a solvent for cyclosporin A. , 1993, Cancer biotherapy.
[29] K. Hande,et al. Metabolism and excretion of etoposide in isolated, perfused rat liver models. , 1988, Cancer research.